Evidence map›Paper›PMID 27147109›Full record

ArticleBMC pregnancy and childbirth2016

Barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in Cross River State, Nigeria: a cross-sectional study.

Soter Ameh, Eme Owoaje, Angela Oyo-Ita, Caroline W Kabiru, Obaji E O Akpet, Aniekan Etokidem, Okokon Enembe, Nnette Ekpenyong

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC pregnancy and childbirth, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Investigating the dynamics ofOpen research Europe · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Soter AmehDepartment of Community Medicine, College of Medical Sciences, University of Calabar, Calabar, Cross River State, Nigeria. sote_ameh@yahoo.com.
Eme OwoajeDepartment of Community Medicine, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.
Angela Oyo-ItaDepartment of Community Medicine, College of Medical Sciences, University of Calabar, Calabar, Cross River State, Nigeria.
Caroline W KabiruAfrican Population and Health Research Center, Nairobi, Kenya.
Obaji E O AkpetDepartment of Community Medicine, College of Medical Sciences, University of Calabar, Calabar, Cross River State, Nigeria.
Aniekan EtokidemDepartment of Community Medicine, College of Medical Sciences, University of Calabar, Calabar, Cross River State, Nigeria.
Okokon EnembeDepartment of Community Medicine, College of Medical Sciences, University of Calabar, Calabar, Cross River State, Nigeria.
Nnette EkpenyongDepartment of Community Medicine, College of Medical Sciences, University of Calabar, Calabar, Cross River State, Nigeria.
University of Calabar · NGAfrican Population and Health Research Center · KEUniversity of Ibadan · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMalaria in pregnancy (MIP) has serious consequences for the woman, unborn child and newborn. The use of sulfadoxine-pyrimethamine for the intermittent preventive treatment of malaria in pregnancy (SP-IPTp) is low in malaria endemic areas, including some regions of Nigeria. However, little is known about pregnant women's compliance with the SP-IPTp national guidelines in primary health care (PHC) facilities in the south-south region of Nigeria. The aim of this study was to identify the barriers to and determinants of the use of SP-IPTp among pregnant women attending ANC in PHC facilities in Cross River State, south-south region of Nigeria.

methodsA cross-sectional survey was conducted in 2011 among 400 ANC attendees aged 15-49 years recruited through multistage sampling. Binary logistic regression was used to determine the factors associated with the use of SP-IPTp in the study population.

resultsUse of SP-IPTp was self-reported by 41% of the total respondents. Lack of autonomy in the households to receive sulfadoxine-pyrimethamine (SP) during ANC was the main barrier to use of IPTp (83%). Other barriers were stock-outs of free SP (33%) and poor supervision of SP ingestion by directly observed treatment among those who obtained SP from ANC clinics (36/110 = 33%). In the multivariate logistic regression, the odds of using SP-IPTp was increased by the knowledge of the use of insecticide treated nets (ITNs) (OR = 2.13, 95% CI: 1.70-3.73) and SP (OR = 22.13, 95% CI: 8.10-43.20) for the prevention of MIP. Use of ITNs also increased the odds of using SP-IPTp (OR = 2.38, 95% CI: 1.24-12.31).

conclusionsUse of SP-IPTp was low and was associated with knowledge of the use of ITNs and SP as well as the use of ITNs for the prevention of MIP. There is a need to strengthen PHC systems and address barriers to the usage of SP-IPTp in order to reduce the burden of MIP.

Indexed as

AdolescentAdultAntimalarialsCross-Sectional StudiesDrug CombinationsFamily CharacteristicsFemaleHealth Services AccessibilityHumansInsecticide-Treated BednetsLogistic ModelsMalariaMiddle AgedNigeriaPatient CompliancePregnancyAntimalarialsDrug Combinationsfanasil, pyrimethamine drug combinationPyrimethamineSulfadoxineBarriersCross River StateDeterminantsIntermittent preventive treatment of malaria in pregnancyNigeriaSulfadoxine-pyrimethamineUse

Identifiers

PMID27147109
PMCPMC4857401
OpenAlexW2347184908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.